Fred Alger Management, LLC Kezar Life Sciences, Inc. Transaction History

Fred Alger Management, LLC

  • $19.8 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$4.58 - $17.13 $781,819 - $2.92 Million
-170,703 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$12.3 - $18.33 $2.1 Million - $3.13 Million
170,703 New
170,703 $2.84 Million
Q2 2019

Aug 14, 2019
SELL
$7.09 - $21.9 $127,620 - $394,200
-18,000 Closed
0 $0
Q1 2019

May 14, 2019
BUY
$16.83 - $23.75 $33,660 - $47,500
2,000 Added 12.5%
18,000 $319,000
Q4 2018

Feb 14, 2019
BUY
$20.21 - $32.9 $323,360 - $526,400
16,000 New
16,000 $378,000

Others Institutions Holding KZR

# of Institutions
61
Shares Held
38.4M
Call Options Held
13.8K
Put Options Held
600
View Full List

About Kezar Life Sciences, Inc.

KZR Quotes by TradingView
  • Ticker KZR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,369,504
  • Market Cap $446M
  • Description
  • Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...
More about KZR
Track This Portfolio

Track Fred Alger Management, LLC Portfolio

Follow Fred Alger Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email